3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
112
Breast Neoplasms
17
Neoplasms
7
Leiomyoma
6
Prostate Adenocarcinoma
3
Polycystic Ovary Syndrome
3
Salivary Gland Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Uveal Melanoma
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasm Duct
1
Recurrence
1
Puberty, Precocious
1
Primary Dysautonomias
1
Premenopausal Breast Cancer
1
Patient Compliance
1
PSA Level Greater Than Two
1
Obesity, Morbid
1
Obesity
1
Myofibroma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Interventions
pembrolizumab
1
exemestane
1
Tamoxifen
1
Surgical Procedures, Operative
1
Leuprolide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Premenopausal Breast Cancer
×
Leuprolide
×
Clear all
NCT02990845
2023-02-22
PEER
National Taiwan University Hospital
Phase 1/2
Terminated
16 enrolled